Co-Authors
This is a "connection" page, showing publications co-authored by MEGHAN SRI KARUTURI and JENNIFER LITTON.
Connection Strength
0.633
-
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2023 Jun; 199(3):457-469.
Score: 0.224
-
Progression-free survival (PFS) and toxicities of palbociclib in a geriatric population. Breast Cancer Res Treat. 2019 Jun; 175(3):667-674.
Score: 0.168
-
Severe hyponatremia following cyclophosphamide infusion in breast cancer patients. Breast J. 2018 07; 24(4):691-692.
Score: 0.157
-
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer. Invest New Drugs. 2021 04; 39(2):509-515.
Score: 0.047
-
Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation. J Cancer. 2017; 8(11):2004-2009.
Score: 0.037